Literature DB >> 26513770

The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes.

Alessandra Malato1, Francesco Dentali2, Sergio Siragusa1, Francesco Fabbiano3, Yoan Kagoma4, Maria Boddi5, Gian Franco Gensini5, Adriano Peris6, Mark Crowther7, Mariasanta Napolitano1.   

Abstract

BACKGROUND: Critically ill patients appear to be at high risk of developing deep vein thrombosis (DVT) and pulmonary embolism during their stay in the intensive care unit (ICU). However, little is known about the clinical course of venous thromboembolism in the ICU setting. We therefore evaluated, through a systematic review of the literature, the available data on the impact of a diagnosis of DVT on hospital and ICU stay, duration of mechanical ventilation and mortality in critically ill patients. We also tried to determine whether currently adopted prophylactic measures need to be revised and improved in the ICU setting.
MATERIALS AND METHODS: MEDLINE and EMBASE databases were searched up to week 4 of June 2012. Two reviewers selected studies and extracted data. Pooled results are reported as relative risks and weighted mean differences and are presented with 95% confidence intervals (CI).
RESULTS: Seven studies for a total of 1,783 patients were included. A diagnosis of DVT was frequent in these patients with a mean rate of 12.7% (95% CI: 8.7-17.5%). DVT patients had longer ICU and hospital stays compared to those without DVT (7.28 days; 95% CI: 1.4-13.15; and 11.2 days; 95% CI: 3.82-18.63 days, respectively). The duration of mechanical ventilation was significantly increased in DVT patients (weighted mean difference: 4.85 days; 95% CI: 2.07-7.63). DVT patients had a marginally significant increase in the risk of hospital mortality (relative risk 1.31; 95% CI: 0.99-1.74; p=0.06), and a not statistically significant increase in the risk of ICU mortality (RR 1.64; 95% CI: 0.91-2.93; p=0.10).
CONCLUSIONS: A diagnosis of DVT upon ICU admission appears to affect clinically important outcomes including duration of ICU and hospital stay and hospital mortality. Larger, prospective studies are warranted.

Entities:  

Mesh:

Year:  2015        PMID: 26513770      PMCID: PMC4624530          DOI: 10.2450/2015.0277-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  26 in total

Review 1.  Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis.

Authors:  J A Sterne; M Egger; G D Smith
Journal:  BMJ       Date:  2001-07-14

Review 2.  The diagnosis of deep venous thrombosis and pulmonary embolism in medical-surgical intensive care unit patients.

Authors:  Deborah Cook; James Douketis; Mark A Crowther; David R Anderson
Journal:  J Crit Care       Date:  2005-12       Impact factor: 3.425

3.  The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis.

Authors:  J S Ginsberg; C Kearon; J Douketis; A G Turpie; P Brill-Edwards; P Stevens; A Panju; A Patel; M Crowther; M Andrew; P Massicotte; J Hirsh; J I Weitz
Journal:  Arch Intern Med       Date:  1997-05-26

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients.

Authors:  D Cook; J Attia; B Weaver; E McDonald; M Meade; M Crowther
Journal:  J Crit Care       Date:  2000-12       Impact factor: 3.425

6.  Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study.

Authors:  M A Crowther; E McDonald; M Johnston; D Cook
Journal:  Blood Coagul Fibrinolysis       Date:  2002-01       Impact factor: 1.276

7.  Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis.

Authors:  Emad H Ibrahim; Manuel Iregui; Donna Prentice; Glenda Sherman; Marin H Kollef; William Shannon
Journal:  Crit Care Med       Date:  2002-04       Impact factor: 7.598

8.  Prevalence of deep venous thrombosis among patients in medical intensive care.

Authors:  D R Hirsch; E P Ingenito; S Z Goldhaber
Journal:  JAMA       Date:  1995-07-26       Impact factor: 56.272

9.  Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study.

Authors:  S M Schellong; J Beyer; A K Kakkar; K Halbritter; B I Eriksson; A G G Turpie; F Misselwitz; P Kälebo
Journal:  J Thromb Haemost       Date:  2007-04-06       Impact factor: 5.824

10.  The incidence of deep venous thrombosis in Chinese medical Intensive Care Unit patients.

Authors:  Gavin M Joynt; Thomas S T Li; James F Griffith; Charles D Gomersall; Florence H Y Yap; Anthony M H Ho; Patricia Leung
Journal:  Hong Kong Med J       Date:  2009-02       Impact factor: 2.227

View more
  34 in total

1.  Association between intravascular thermoregulation devices and the development of venous thrombo-embolic phenomenon.

Authors:  Sophie Winder-Rhodes; Rosamund Lotay; James Doyle
Journal:  J Intensive Care Soc       Date:  2017-07-24

2.  A Multicenter Observational Cohort Study of Angiotensin II in Shock.

Authors:  Susan E Smith; Andrea S Newsome; Yanglin Guo; Jason Hecht; Michael T McCurdy; Michael A Mazzeffi; Jonathan H Chow; Shravan Kethireddy
Journal:  J Intensive Care Med       Date:  2020-11-24       Impact factor: 3.510

3.  A retrospective cohort study of disease-related risk factors for central venous catheter-related symptomatic thrombosis in intensive care unit inpatients.

Authors:  Zhiming Kuang; Xiaochun Liu; Yunlin Zhu; Hailiang Xie; Yuanfei Liu
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

4.  The Incidence of Venous Thromboembolism in Critically Ill Patients with SARS-CoV-2 Infection Compared with Critically Ill Influenza and Community-Acquired Pneumonia Patients: A Retrospective Chart Review.

Authors:  Sean Boyd; Kai Sheng Loh; Jessie Lynch; Dhari Alrashed; Saad Muzzammil; Hannah Marsh; Mustafa Masoud; Salman Bin Ihsan; Ignacio Martin-Loeches
Journal:  Med Sci (Basel)       Date:  2022-06-08

5.  Prevalence of Deep Vein Thrombosis in Patients Supported With Extracorporeal Membrane Oxygenation.

Authors:  Zo G S Vazquez; Neel R Sodha; Cynthia Devers; Corey E Ventetuolo; Adeel Abbasi
Journal:  ASAIO J       Date:  2021-10-01       Impact factor: 3.826

Review 6.  Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism.

Authors:  Claudio Tana; Fulvio Lauretani; Andrea Ticinesi; Beatrice Prati; Antonio Nouvenne; Tiziana Meschi
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

7.  A Pilot Study to Assess Safety and Feasibility of Intrathecal Immunoglobulin for the Treatment of Adults with Tetanus.

Authors:  Huynh Thi Loan; Lam Minh Yen; Evelyne Kestelyn; Nguyen Van Hao; Nguyen Thi Hoang Mai; Duong Bich Thuy; Ha Thi Hai Duong; Nguyen Thi Phuong Dung; Nguyen Hoan Phu; Pham Thi Lieu; Tran Tan Thanh; Ronald Geskus; H Rogier van Doorn; Le Van Tan; Duncan Wyncoll; Nicholas P J Day; Tran Tinh Hien; Guy E Thwaites; Nguyen Van Vinh Chau; C Louise Thwaites
Journal:  Am J Trop Med Hyg       Date:  2018-06-14       Impact factor: 2.345

8.  Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.

Authors:  Christina Creel-Bulos; Sara C Auld; Mark Caridi-Scheible; Nicholas A Barker; Sarah Friend; Manila Gaddh; Christine L Kempton; Cheryl L Maier; Fadi Nahab; Roman Sniecinski
Journal:  Shock       Date:  2021-03-01       Impact factor: 3.454

9.  Unusual Presentation of a Severe COVID-19 Case With Axillary Artery Thrombosis.

Authors:  Fadi S Aljamaan
Journal:  Cureus       Date:  2021-05-15

10.  Effect of red blood cell transfusion on inflammation, endothelial cell activation and coagulation in the critically ill.

Authors:  Lisa van Manen; Maike E van Hezel; Margit Boshuizen; Marleen Straat; Angelique M E de Man; Charlotte Dekimpe; Karen Vanhoorelbeke; Robin van Bruggen; Nicole P Juffermans
Journal:  Vox Sang       Date:  2021-07-01       Impact factor: 2.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.